Ubiquitech Software Stock Buy Hold or Sell Recommendation
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Ubiquitech Software is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Ubiquitech Software given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Ubiquitech Software, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Ubiquitech Software Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ubiquitech and provide practical buy, sell, or hold advice based on investors' constraints. Ubiquitech Software. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Ubiquitech |
Execute Ubiquitech Software Buy or Sell Advice
The Ubiquitech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ubiquitech Software. Macroaxis does not own or have any residual interests in Ubiquitech Software or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ubiquitech Software's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Not Rated
Ubiquitech Software Trading Alerts and Improvement Suggestions
Ubiquitech Software is way too risky over 90 days horizon | |
Ubiquitech Software has some characteristics of a very speculative penny stock | |
Ubiquitech Software appears to be risky and price may revert if volatility continues | |
Ubiquitech Software currently holds 697.58 K in liabilities. Ubiquitech Software has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Ubiquitech Software until it has trouble settling it off, either with new capital or with free cash flow. So, Ubiquitech Software's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ubiquitech Software sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ubiquitech to invest in growth at high rates of return. When we think about Ubiquitech Software's use of debt, we should always consider it together with cash and equity. |
Ubiquitech Software Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ubiquitech Software or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ubiquitech Software's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ubiquitech pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 371.74 | |
Ir | Information ratio | 0.00 |
Ubiquitech Software Volatility Alert
At this time Ubiquitech Software exhibits very low volatility. You can indeed make money on Ubiquitech instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ubiquitech Software Fundamentals Vs Peers
Comparing Ubiquitech Software's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ubiquitech Software's direct or indirect competition across all of the common fundamentals between Ubiquitech Software and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ubiquitech Software or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Ubiquitech Software's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ubiquitech Software by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Ubiquitech Software to competition |
Fundamentals | Ubiquitech Software | Peer Average |
Return On Asset | -30.26 | -0.14 |
Current Valuation | 176.15 K | 16.62 B |
Shares Outstanding | 14.56 M | 571.82 M |
Price To Earning | (1.60) X | 28.72 X |
Revenue | 4.51 M | 9.43 B |
Net Income | 352.45 K | 570.98 M |
Total Debt | 697.58 K | 5.32 B |
Current Ratio | 0.68 X | 2.16 X |
Cash Flow From Operations | 244.26 K | 971.22 M |
Earnings Per Share | (0) X | 3.12 X |
Number Of Employees | 4 | 18.84 K |
Beta | 22.56 | -0.15 |
Market Capitalization | 176.15 K | 19.03 B |
Total Asset | 2.16 M | 29.47 B |
Retained Earnings | 11 K | 9.33 B |
Working Capital | 1.04 M | 1.48 B |
Current Asset | 1.06 M | 9.34 B |
Current Liabilities | 15 K | 7.9 B |
Z Score | 2.0 | 8.72 |
Net Asset | 2.16 M |
About Ubiquitech Software Buy or Sell Advice
When is the right time to buy or sell Ubiquitech Software? Buying financial instruments such as Ubiquitech Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ubiquitech Software in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Ubiquitech Pink Sheet Analysis
When running Ubiquitech Software's price analysis, check to measure Ubiquitech Software's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ubiquitech Software is operating at the current time. Most of Ubiquitech Software's value examination focuses on studying past and present price action to predict the probability of Ubiquitech Software's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ubiquitech Software's price. Additionally, you may evaluate how the addition of Ubiquitech Software to your portfolios can decrease your overall portfolio volatility.